| Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action DI Edwards Journal of Antimicrobial Chemotherapy 31 (1), 9-20, 1993 | 754 | 1993 |
| Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities JE Coia, GJ Duckworth, DI Edwards, M Farrington, C Fry, H Humphreys, ... Journal of hospital infection 63, S1-S44, 2006 | 696 | 2006 |
| Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA) DFJ Brown, DI Edwards, PM Hawkey, D Morrison, GL Ridgway, ... Journal of antimicrobial chemotherapy 56 (6), 1000-1018, 2005 | 663 | 2005 |
| Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK CG Gemmell, DI Edwards, AP Fraise, FK Gould, GL Ridgway, RE Warren Journal of antimicrobial chemotherapy 57 (4), 589-608, 2006 | 517 | 2006 |
| Reduction of nitroimidazoles in vitro and DNA damage DI Edwards Biochemical pharmacology 35 (1), 53-58, 1986 | 181 | 1986 |
| Nitroimidazole drugs-action and resistance mechanisms II. Mechanisms of resistance DI Edwards Journal of Antimicrobial Chemotherapy 31 (2), 201-210, 1993 | 172 | 1993 |
| The selective toxicity of antimicrobial nitroheterocyclic drugs DI Edwards, M Dye, H Carne Microbiology 76 (1), 135-145, 1973 | 168 | 1973 |
| The interaction of reduced metronidazole with DNA RC Knight, IM Skolimowski, DI Edwards Biochemical pharmacology 27 (17), 2089-2093, 1978 | 161 | 1978 |
| Studies on DNA damage and induction of SOS repair by novel multifunctional bioreducible compounds. II. A metronidazole adduct of a ruthenium-arene compound. LD Dale, JH Tocher, TM Dyson, DI Edwards, DA Tocher Anti-Cancer Drug Design 7 (1), 3-14, 1992 | 153 | 1992 |
| Metronidazole resistance in Helicobacter pylori PJ Jenks, DI Edwards International Journal of antimicrobial agents 19 (1), 1-7, 2002 | 141 | 2002 |
| Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs. DI Edwards Sexually Transmitted Infections 56 (5), 285-290, 1980 | 134 | 1980 |
| Hospital Infection Society; Infection Control Nurses Association. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare … JE Coia, GJ Duckworth, DI Edwards, M Farrington, C Fry, H Humphreys, ... J Hosp Infect 63 (Suppl 1), S1-44, 2006 | 128 | 2006 |
| Electrochemical characteristics of nitro-heterocyclic compounds of biological interest: I. The influence of solvent JH Tocher, DI Edwards Free Radical Research Communications 4 (5), 269-276, 1988 | 127* | 1988 |
| The Mode of Action of Metronidazole against Trichomonas vaginalis DI Edwards, GE Mathison Microbiology 63 (3), 297-302, 1970 | 108 | 1970 |
| Mechanism of antimicrobial action of metronidazole DI EDWARDS Journal of Antimicrobial Chemotherapy 5 (5), 499-502, 1979 | 106 | 1979 |
| Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases JH Tocher, DI Edwards Biochemical pharmacology 48 (6), 1089-1094, 1994 | 102 | 1994 |
| Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs MA Smith, DI Edwards Journal of Antimicrobial Chemotherapy 35 (6), 751-764, 1995 | 98 | 1995 |
| The action of metronidazole on DNA DI Edwards Journal of Antimicrobial Chemotherapy 3 (1), 43-48, 1977 | 97 | 1977 |
| Hospital Infection Society; Infection Control Nurses Association. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus … DF Brown, DI Edwards, PM Hawkey, D Morrison, GL Ridgway, KJ Towner, ... J Antimicrob Chemother 56 (6), 1000-18, 2005 | 96 | 2005 |
| Studies on the action of nitroimidazole drugs: The products of nitroimidazole reduction RJ Knox, RC Knight, DI Edwards Biochemical pharmacology 32 (14), 2149-2156, 1983 | 81 | 1983 |
